Delivery Order SPE2DB20D1109-SPE2DB24FN79S

Award Date 3/12/24
Potential Completion Date 3/13/24
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,877.08 delivery order contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a period of performance through February 28, 2024. The award is not associated with a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This federal contract award, valued at $1,936.65, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4564413056 - MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary...
This federal contract award, valued at $2,775.24, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,053.59 for the supply of MULTAQ 400 MG TABLET 60S. The contract has a firm fixed price and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,695.78 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The award has an ultimate completion date of December 28, 2023. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $5,958.23 for the supply of MULTAQ 400 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on January 29, 2024, with a completion date of January 30, 2024. The contract is a Firm Fixed Price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,857.00 firm fixed-price delivery order is for the provision of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2023. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DX24F0JZA) with a Firm Fixed Price valued at $24,340.63. The award is issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that supports military healthcare programs. The contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to...
This federal contract award, valued at $13,352.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,953.39 firm-fixed-price contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FN79S
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The $2,227.14 fixed-price delivery order covers the supply of 4563943278 MULTAQ 400 MG TABLET 60S, a cardiovascular medication.

The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense and veteran healthcare programs worldwide. This delivery order does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:55 AM